Joshua Silverman
CEO and President at PharmaCyte Biotech · 12 reported transactions in 4 companies · latest trade Jan 7, 2026
Their record
Across their whole record, 1 purchase can be measured; 0 did better than the S&P 500 over the next 6 months.
Typical move −4.1%, S&P 500 +7.7% over the same days.
Their trades
Bought | Jan 7, 2026 | Jan 7, 2026 close $0.83 → Oct 26, 2026 close $0.35. S&P 500 +11.0% over the same days. | ||
Bought | Jan 6, 2026 | Jan 6, 2026 close $0.77 → Oct 26, 2026 close $0.35. S&P 500 +10.6% over the same days. | ||
Bought | Jan 5, 2026 | Jan 5, 2026 close $0.76 → Oct 26, 2026 close $0.35. S&P 500 +11.3% over the same days. |
BoughtPharmaCyte Biotech
$33.3K
Jan 7, 2026 close $0.83 → Oct 26, 2026 close $0.35. S&P 500 +11.0% over the same days.
BoughtPharmaCyte Biotech
$23.7K
Jan 6, 2026 close $0.77 → Oct 26, 2026 close $0.35. S&P 500 +10.6% over the same days.
BoughtPharmaCyte Biotech
$23.5K
Jan 5, 2026 close $0.76 → Oct 26, 2026 close $0.35. S&P 500 +11.3% over the same days.